Mitchell H. Finer is Chief Scientific Officer at bluebird bio, Inc. (BLUE). They have made 1 open-market trade across 1 company since 2013, most recently 2017-06-12.
CIK 0001578432
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BLUE | SELL · 10b5-1 | 2015-06-01 | 2015-06-03 | $190.25 | $2.9M | -26.5% | +1.0% | +1.0% |
| BLUE | SELL · 10b5-1 | 2015-05-22 | 2015-05-27 | $170.32 | $2.6M | -26.5% | +1.0% | +1.0% |
| BLUE | SELL · 10b5-1 | 2015-05-15 | 2015-05-19 | $154.33 | $2.3M | -26.5% | +1.0% | +1.0% |
| BLUE | SELL · 10b5-1 | 2015-05-04 | 2015-05-06 | $131.84 | $2.0M | -26.5% | +1.0% | +1.0% |
| BLUE | SELL · 10b5-1 | 2015-04-20 | 2015-04-22 | $126.03 | $1.9M | -26.5% | +1.0% | +1.0% |
| BLUE | SELL · 10b5-1 | 2015-04-06 | 2015-04-08 | $118.72 | $1.8M | -26.5% | +1.0% | +1.0% |
| BLUE | SELL · 10b5-1 | 2015-04-01 | 2015-04-03 | $117.95 | $3.5M | -26.5% | +1.0% | +1.0% |
| BLUE | SELL · 10b5-1 | 2015-01-02 | 2015-01-06 | $90.01 | $2.7M | -26.5% | +1.0% | +1.0% |
| BLUE | SELL · 10b5-1 | 2014-12-01 | 2014-12-03 | $39.70 | $715K | -26.5% | +1.0% | +1.0% |
| BLUE | SELL | 2014-10-08 | 2014-10-10 | $33.52 | $1.2M | -26.5% | +1.0% | +1.0% |
| BLUE | SELL · 10b5-1 | 2014-09-02 | 2014-09-03 | $38.00 | $684K | -26.5% | +1.0% | +1.0% |
| BLUE | SELL · 10b5-1 | 2014-06-16 | 2014-06-18 | $39.84 | $398K | -26.5% | +1.0% | +1.0% |
| BLUE | SELL · 10b5-1 | 2014-06-02 | 2014-06-04 | $22.21 | $178K | -26.5% | +1.0% | +1.0% |
| BLUE | SELL · 10b5-1 | 2014-03-03 | 2014-03-05 | $24.79 | $198K | -26.5% | +1.0% | +1.0% |
| BLUE | SELL · 10b5-1 | 2014-01-16 | 2014-01-17 | $23.52 | $235K | -26.5% | +1.0% | +1.0% |
| BLUE | SELL · 10b5-1 | 2013-12-16 | 2013-12-18 | $20.65 | $372K | -26.5% | +1.0% | +1.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.